Stains and Reagents Market Opportunities, Business Forecast To 2029

The global stains and reagents market size was valued at USD 4,312.7 million in 2022, growing at a CAGR of 6.0% during the forecast period 2023 to 2029. The primary drivers of the expansion of the global stains and reagents market include the increasing prevalence of chronic infectious disease and their advanced diagnostics for treatment. In addition, increasing investments in research and development by the key market players is expected to boost the market growth.

View the detailed report description here - https://precisionbusinessinsights.com/market-reports/stains-and-reagents-market

Hospital & Diagnostic Laboratory Centers Segment is expected to Dominate the Stains and Reagents Market:
Based on the end-user, the global Stains and Reagents market is segmented into Hospitals, Diagnostic Laboratory Centers, Academics and Research Institutes. The Hospital & diagnostic laboratory centres segment is expected to account for a larger revenue share in the global stains and reagents market owing to the larger cancer and infectious disease diagnosis as the diagnosis is the primary step in the treatment of infectious disease. The rising prevalence of infectious disease and its treatment, advantages of modern straining system over the conventional method of straining and increase in investments in research and developments are the key drivers of stains and reagents market in this segment.

North America Stains and Reagents Market:
The North America stains and reagents market is expected to increase over the forecast period due to the several market players present in this region. Rapid adoption of technically advanced instruments, increase in investments in research and development are some of the key factors driving the growth of stains and reagent market in this region. In addition, well established healthcare infrastructure in this region is expected to fuel the market growth in this region. the rising economies like Canada and USA are leading in biological research across the globe which is again expected to propel the market growth in this region. Europe and Asia Pacific region are expected to have a significant growth due to the well-established health care infrastructure and increase in pharmaceutical and biotechnological research in region.

Strategic New Product Launches, Mergers, Acquisitions, and Agreements are the key strategies adopted by market players:
The global Stains and Reagents market further reveals that the key players are increasingly adopting strategies such as the launch of newer products, product launches, and long-term alliances to improve market revenue share and gain significant geographic presence across the region. For instance, In August 2022, Abcam plc announced a merger with twist bioscience to discover, develop, and commercialize of antibody, In June 2021, Thermo Fisher acquired PPD, expanding their value proposition for biotech and pharmaceutical customers.

Request sample report at https://precisionbusinessinsights.com/request-sample/?product_id=554412

The Stains and Reagents market is segmented based on Product Type, Technology, End User, and geography.

Based on the product type, the market is segmented into the following:
• Staining System
• Staining Reagents
• Accessories
Based on the technology, the market is segmented into the following:
• Hematoxylin and Eosin
• Immunohistochemistry
• In Situ Hybridization
• Cytology
• Microbiology
• Hematology
• Special Stains

Based on the end user, the market is segmented into the following:
• Hospitals
• Diagnostic Laboratory Centers
• Academics & Research Institutes
• Others

Based on geography, the market is segmented into the following:
• North America
• Europe
• The Asia Pacific
• Latin America
• MEA

Key players profiles in the Stains and Reagents market report are F. Hoffmann-La Roche Ltd., Danaher Corporation, PHC Holdings Corporation, Thermo Fisher Scientific, Inc., Merck KGAA, Agilent Technologies, Inc., Abcam Plc., Becton, Dickinson and Company, Siemens Healthineers AG, BioCare Medical, LLC, Hardy Diagnostics, General Data Company, ELI Tech Group.

Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.